Nuchev Ltd (ASX: NUC) Share Price and News
Price
$0.225
Movement
0.00 (0.0)
as at 9 May - Closed (20 mins delayed)
52 Week Range
$0.11 - $0.35
1 Year Return
+40.63%
Nuchev Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$32.93 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
146.34 million
Earnings per share
-0.056
Dividend per share
N/A
Year To Date Return
87.50%
Earnings Yield
N/A
Franking
-
Share Price
$0.225
Day Change
0.00 (0.0)
52 Week Range
$0.11 - $0.35
Yesterday's Close
$0.225
Today's Open
–
Days Range
– - –
Volume
0
Avg. Volume (1 month)
16,858
Turnover
$0
as at 9 May - Closed
Should you invest $1,000 in Nuchev Limited right now?
Before you buy Nuchev Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys...
See The 5 Stocks *Returns as of 30 April 2025
Nuchev Ltd (ASX: NUC)
Latest News
Share Gainers
Why Iron Road, Nuchev, Telix, & Treasury Wine shares are pushing higher today
Shares to Watch
Should you buy these 2 ASX dairy shares instead of A2 Milk?
Growth Shares
A2 Milk and 1 other top ASX growth share to buy this month
Share Market News
3 quarterly updates you might have missed: Champion Iron, Life360, & Nuchev
Share Market News
Why I'd buy and hold a2 Milk shares until 2025
Share Market News
Is the a2 Milk share price too high to buy?
Share Market News
Fund managers have been buying these ASX shares this week
Share Market News
This ASX infant formula share just reported explosive growth. Could it be the next a2 Milk?
Share Market News
2 ASX 200 companies playing a vital role in the coronavirus crisis
Share Market News
3 ASX shares to buy with $3,000
Share Market News
3 top ASX growth shares to diversify your portfolio
Share Market News
3 ASX growth shares to buy and hold beyond 2025
1❯
NUC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| 1st May 2025 2025-05-01T11:16:30 | Nuchev enters into Agency Agreement with H&S and Brauer | YesNo | 11:16am | 2 | 328k |
| 29th Apr 2025 2025-04-29T09:11:41 | Quarterly Activities Report & Appendix 4C | YesNo | 9:11am | 7 | 669k |
| 2nd Apr 2025 2025-04-02T13:03:27 | Notification of cessation of securities - NUC | YesNo | 1:03pm | 4 | 14k |
| 31st Mar 2025 2025-03-31T20:18:21 | Correction - Change of Directors Interest Notice | YesNo | 8:18pm | 3 | 1.3M |
| 17th Mar 2025 2025-03-17T11:17:09 | Notice of Initial Substantial Holder | YesNo | 11:17am | 2 | 364k |
| 17th Mar 2025 2025-03-17T11:11:49 | Change of Director's Interest Notice - CS | YesNo | 11:11am | 3 | 404k |
| 11th Mar 2025 2025-03-11T17:52:14 | NUC Expands into Vietnam Market with Oli6 Nutritionals Range | YesNo | 5:52pm | 2 | 293k |
| 27th Feb 2025 2025-02-27T17:43:13 | Half Year Results Release | YesNo | 5:43pm | 17 | 1.1M |
| 27th Feb 2025 2025-02-27T17:42:13 | Half Year Report and Accounts | YesNo | 5:42pm | 20 | 694k |
| 27th Feb 2025 2025-02-27T17:40:43 | Appendix 4D to 31 December 2024 | YesNo | 5:40pm | 1 | 135k |
About Nuchev Ltd
Nuchev Ltd is a globally-oriented food business focused on developing, marketing, and selling a range of premium Australian made goat nutritional products. Its primary products include those branded under the Oli6 Bio Practica and MedicineTree and a number of globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness.
NUC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 07 May 2025 | $0.23 | $0.00 | 0.00% | 1,439 | $0.23 | $0.23 | $0.23 |
| 06 May 2025 | $0.23 | $-0.01 | -4.35% | 41,929 | $0.23 | $0.23 | $0.23 |
| 02 May 2025 | $0.23 | $0.02 | 9.30% | 15,000 | $0.22 | $0.23 | $0.22 |
| 01 May 2025 | $0.22 | $0.03 | 15.79% | 143,894 | $0.20 | $0.22 | $0.20 |
| 30 Apr 2025 | $0.19 | $0.03 | 18.75% | 7,784 | $0.19 | $0.19 | $0.19 |
| 29 Apr 2025 | $0.16 | $-0.02 | -11.43% | 35,848 | $0.18 | $0.19 | $0.16 |
| 28 Apr 2025 | $0.18 | $0.01 | 6.06% | 74,414 | $0.17 | $0.18 | $0.16 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 12 Mar 2025 | Craig Silbery | Buy | 30,000 | $5,736 |
On-market trade.
|
| 11 Mar 2025 | Craig Silbery | Buy | 10,000 | $1,912 |
On-market trade.
|
| 07 Mar 2025 | Craig Silbery | Buy | 20,000 | $3,824 |
On-market trade.
|
| 22 Jan 2025 | Nathan Cheong | Issued | 261,328 | $33,450 |
Director remuneration. 261,328 - Share Rights
|
| 22 Jan 2025 | Ben Dingle | Issued | 479,102 | $61,325 |
Director remuneration. 479,102 - Share Rights
|
| 22 Jan 2025 | Elizabeth Smith (Liz) | Issued | 278,750 | $35,680 |
Director remuneration. 278,750 - Share Rights
|
| 22 Jan 2025 | Craig Silbery | Issued | 474,746 | $60,767 |
Director remuneration. 474,746 - Share Rights
|
| 19 Dec 2024 | Ben Dingle | Expiry | 410,887 | $47,252 |
Options expired.
|
| 29 Jul 2024 | Ben Dingle | Expiry | 1,646,090 | $296,296 |
Options expired.
|
| 27 Jun 2024 | Ben Dingle | Issued | 5,769,231 | $900,000 |
Rights issue.
|
| 27 Jun 2024 | Craig Silbery | Issued | 2,271,561 | $354,363 |
Rights issue.
|
| 27 Jun 2024 | Craig Silbery | Issued | 1,342,766 | $209,471 |
Rights issue.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ben McFarlane Dingle | Non-Executive ChairmanNon-Executive Director | Oct 2023 |
Mr Dingle founded Nuchev and was CEO between 2013 and October 2022. Ben is recognized as a highly connected, large-scale dairy innovator and leader. He has commercial experience in the wider dairy nutritional sector, having co-founded New Zealand's Synlait Group in 1999, and later played a pivotal role in steering the IPO of Synlait Milk in 2013. Ben was also instrumental in the creation and management of a portfolio encompassing expansive dairy operations on the Canterbury Plains, which included approximately 15,000 cows. In this role, he established and implemented innovative irrigation schemes, and the incorporation of world best farming practices. Before co-founding Synlait Milk, Ben owned and managed a portfolio of dairy operations in the Waikato region.
|
| Ms Elizabeth Smith (Liz) | Non-Executive Director | Jul 2024 |
Ms Smith has executive career includes Corporate Finance Partner roles at William Buck and Grant Thornton, as well as audit experience at Ernst & Young. L Smith is on the Board of the Australian Red Cross Pureprofile (ASX:PPL) and BikeExchange (formerly ASX: BEX). L Smith has skills in finance and accounting, strategy, M&A, risk and governance and experience advising businesses. She has worked across a range of industries (including food and fast-moving consumer goods) and for businesses ranging from small privately owned companies to large ASX listed entities.
|
| Mr Craig Silbery | Non-Executive Director | Oct 2023 |
Mr Silbery has been a Non-Executive Director of Nuchev since October 2023. Craig is a respected entrepreneur who established and led Life-Space Group from start-up to a successful exit with the sale to Guangzhou based By-Health in 2018. He built Life-Space around a core foundation of innovative probiotic formulas for infants and pregnant women based on Human Microbiome science.
|
| Ms Tamara Barr | Company Secretary | Feb 2022 |
-
|
| Mr Michael(Mick) Loe Myers | Chief Executive Officer | Dec 2023 |
-
|
| Michael(Mick) Loe Myers | Chief Executive Officer |
-
|
|
| Eddie MacDonald | Chief Financial Officer |
-
|
|
| Helen Hovenga | Chief People Officer |
-
|
|
| Tamara Barr | Company Secretary |
-
|
|
| Roberta Barbiellini | General Manager bWellness |
-
|
|
| Simon Heagney | General Manager Supply Chain |
-
|
|
| Scott Koetsier | Head of Sales and Business Development |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| H&S Investments Australia Pty Ltd H&S Investment Unit A/C> (including Brauer) | 66,818,031 | 45.66% |
| Ben Dingle | 37,853,680 | 25.87% |
| Hsbc Custody Nominees (Australia) Limited | 12,564,873 | 8.59% |
| Mr Craig Silbery | 5,035,370 | 3.44% |
| Mr Craig Silbery Silbery Super Fund A/C> | 2,271,561 | 1.55% |
| Gigo Investment Pty Ltd Gigo A/C> | 1,374,949 | 0.94% |
| CW Investment Holdings Pty Ltd CW Investment Holdings A/C> | 1,030,000 | 0.70% |
| Kirwood Capital Direct Investments 1 Pty Ltd Kirwood Cap Direct Invest 1> | 1,000,000 | 0.68% |
| Finclear Services Pty Ltd Superhero Securities A/C> | 956,029 | 0.65% |
| Justin Breheny | 937,008 | 0.64% |
| Powers Pty Ltd | 900,000 | 0.62% |
| Top End Enterprises Pty Ltd Atkins Family A/C> | 892,644 | 0.61% |
| Ataturk Investments Pty Ltd | 646,031 | 0.44% |
| Bk Custodian Pty Ltd Earle/Blackwell Family A/C> | 484,356 | 0.33% |
| MF & SA Super Pty Ltd MF & SA Super A/C> | 477,570 | 0.33% |
| Daho Pty Ltd The DHB S/F A/C> | 450,000 | 0.31% |
| Souvenir Paradise Pty Ltd | 400,000 | 0.27% |
| C&L Chen Pty Ltd C&L Chen Li SF A/C> | 322,159 | 0.20% |
| Mr Pynith Charernsirivathin & Mrs Zina Christina Charernsirivathin | 300,000 | 0.21% |
| Mr John Leon Trabinger | 299,999 | 0.21% |